- ￥880 - 1320
- CUSABIO
- CN
- CSB-PA345921EB01HDB
- 2025年07月15日
- ELISA
- Copper-metallothionein
- Roman snail
企业认证
相关产品推荐更多 >
IRX2抗体IRX2一抗抗体IrxA2 antibody抗体IRX2 Antibody抗体
￥880
KLK2抗体KLK2兔多抗抗体Ton antibody抗体KLK2 Antibody, Biotin conjugated抗体
￥880
STK38L抗体STK38L兔多抗抗体Stk38l antibody抗体STK38L Antibody, FITC conjugated抗体
￥880
FOXE3抗体FOXE3兔多抗抗体FREAC8 antibody抗体FOXE3 Antibody, Biotin conjugated抗体
￥880DNMT3B抗体DNMT3B兔多抗抗体RP23-89H14.3 antibody抗体DNMT3B Antibody, HRP conjugated抗体
￥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Helix pomatia Copper-metallothionein protein (1-64aa)
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性：
Polyclonal
- 标记物：
HRP
- 适应物种：
Roman snail
- 保质期：
6个月
- 抗原来源：
Helix pomatia (Roman snail) (Edible snail)
- 目录编号：
P55947
- 级别：
优
- 库存：
200
- 供应商：
武汉华美生物工程有限公司
- 宿主：
Copper-metallothionein
- 应用范围：
ELISA
- 浓度：
>95%,Antigen Affinity purified & Affinity purified
- 靶点：
/
- 抗体英文名：
Copper-metallothionein Antibody, HRP conjugated
- 抗体名：
Copper-metallothionein antibody;Cu-MT antibody
- 规格：
100μl/50μl
| 规格： | 100μl | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 50μl | 产品价格： | ￥880.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
功能
The metallothioneins are involved in the cellular sequestration of toxic metal ions and regulation of essential trace elements. This isoform binds exclusively copper.风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Conjugation of Antibody to HRP
the first peak. Preparation of Ab:HRP Conjugate Immediately mix the HRP with the thiolated antibody at 1 mg HRP per mg antibody. Gently stir for 16-20 hours at 2-8oC. Dialyze against 3 changed of PBS, changing every 2 hours, 100X the conjugate
Conjugation of Antibody to HRP
the first peak. Preparation of Ab:HRP Conjugate Immediately mix the HRP with the thiolated antibody at 1 mg HRP per mg antibody. Gently stir for 16-20 hours at 2-8o C
双特异抗体(Bispecific antibody)的简介和制作方法
,inflammatory cytokines, chemotherapeutics or prodrugs. There is a growing number of approved cancer therapeutics that are efficacious either as chimerized antibody or humanized IgG1,or as conjugate with chemotherapeutics or a radioisotope. In spite
技术资料暂无技术资料 索取技术资料
